Psoriasis - A possible candidate for vaccination

Autoimmunity Reviews

Volumn 6, Issue 5, 2007, Pages 286-289

  Fry, Lionel ^a   Baker, Barbara S ^a   Powles, Anne V ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Peptidoglycan; Psoriasis; Streptococcus; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; PEPTIDOGLYCAN; STREPTOCOCCUS ANTIGEN;

BACTERIAL CELL WALL; BACTERIAL INFECTION; CHRONIC DISEASE; CLINICAL FEATURE; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; GENE LOCUS; HISTOLOGY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; NONHUMAN; PHARYNGITIS; PROGNOSIS; PSORIASIS; REVIEW; SKIN DISEASE; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION; VACCINATION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PSORIASIS; STREPTOCOCCAL INFECTIONS; VACCINATION;

EID: 33947714923     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.09.007     Document Type: Review

References (21)

1. Lomholt G. Psoriasis: prevalence, spontaneous course and genetics (1963), G.E.C. Gad, Copenhagen
2. Hellgren L. Psoriasis (1967), Almqvist and Wiksell, Stockholm
3. Hensler T., and Christophers E. Psoriasis of early and late onset: characteristics of two types of psoriasis. J Am Acad Dermatol 13 (1985) 450-456
4. Gudjonsson J., Karason A., Runarsdottir E., Antonsdottir A., Hauksson V.B., Jonsson H.H., et al. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients - an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126 (2006) 740-745
5. Fry L., Powles A.V., Corcoran S., Rogers S., Ward J., and Unsworth D.J. HLA Cw*06 is not essential for streptococcal induced psoriasis. Br J Dermatol 154 (2006) 850-853
6. Baker B.S., Ovigne J.M., Fischetti V.A., Powles A.V., and Fry L. Reduced gamma IFN responses associated with HLA-DR 15 presentation of streptococcal cell wall proteins to dermal Thl cells in psoriasis. J Clin Immunol 23 (2003) 407-415
7. Helms C., Cao L., Krueger J.G., Wijsman E.M., Chamion F., Gordon D., et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility in psoriasis. Nat Genet 35 (2003) 349-356
8. Hewett D., Samuelsson L., Polding I., Enlund F., Smart D., Cantone K., et al. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localised single nucleotide polymorphism map. Genomics 79 (2002) 305-314
9. Zenz R., Efert R., Kerner L., Florin L., Hummerich L., Mehic D., et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437 (2005) 369-375
10. Norholm-Pederson A. Infections and psoriasis. Acta Derm-Venereol 32 (1952) 159-167
11. Belew P.W., Wannamaker L.W., Johnson D., and Rosenberg E.W. Beta haemolytic streptococcal types associated with psoriasis. In: Kimera K., Kotanie S., and Shiokawa Y. (Eds). Recent advances of streptococcal diseases (1985), Reedbooks Ltd., UK 334
12. Telfer N.R., Chalmers R.J., Whale K., and Coleman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 128 (1992) 39-52
13. Wardrop P., Weller R., Marais J., and Kavanagh G. Tonsillitis and chronic psoriasis. Clin Otolaryngol 23 (1998) 67-68
14. Cohen-Tervaert W.C., and Esseveld H.A. A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis with reference to their role in the pathogenesis of the disease. Dermatologica 140 (1970) 282-290
15. Lewis H.M., Baker B.S., Bokt S., Powles A.V., Garioch J.J., Valdimarsson H., et al. Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 129 (1993) 514-520
16. Gudjonsson J., Johnston A., Sigmundsdottir H., and Valdimarsson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 35 (2004) 1-8
17. Leung D.Y.M., Travers J.B., Giorno R., Norris D.A., Skinner R., Aelion J., et al. Evidence of streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 96 (1995) 2106-2117
18. Brown D.W., Baker B.S., Ovigne J.M., Vischetti V.A., Hardman C., Powles A.V., et al. Non M-proteins on the cell wall and membrane of Group A streptococcus induce(s) IFN gamma production by dermal CD4+ T cells in psoriasis. Arch Dermatol Res 293 (2001) 165-170
19. Baker B.S., Brown D.W., Fishetti V.A., Ovigne J.M., Porter W., Powles A.V., et al. Skin T cell proliferative responses to M protein and other cell wall and membrane proteins of Group A streptococci in chronic plaque psoriasis. Clin Exp Immunol 124 (2001) 516-521
20. Baker B.S., Laman J.D., Powles A.V., van der Fits L., Voerman J.S.A., Melief M.-J., and Fry L. Peptidoglycan and peptidoglycan-specific Thl cells in psoriasis. J Pathol 209 (2006) 174-178
21. Van Heel D.A., Ghosh S., Butter M., Hunt K.A., Lundberg A.M.C., Ahmad T., et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2 associated Crohn's disease. Lancet 365 (2005) 1794-1796